Torrent Pharmaceuticals is currently trading at Rs. 2679.90, up by 155.20 points or 6.15% from its previous closing of Rs. 2524.70 on the BSE.
The scrip opened at Rs. 2555.10 and has touched a high and low of Rs. 2681.00 and Rs. 2543.05 respectively. So far 9631 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2,681.00 on 05-Feb-2024 and a 52 week low of Rs. 1446.15 on 01-Mar-2023.
Last one week high and low of the scrip stood at Rs. 2,681.00 and Rs. 2415.00 respectively. The current market cap of the company is Rs. 89958.80 crore.
The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 21.30% and 7.45% respectively.
Torrent Pharmaceuticals has reported 26.92% rise in net profit at Rs 297 crore for the third quarter ended December 31, 2023 as compared to Rs 234 crore for the same quarter in the previous year. Total income of the company increased by 9.43% at Rs 2112 crore for Q3FY24 as compared Rs 1930 crore for corresponding quarter of the previous year.
On consolidated basis, the company reported 51.71% rise in its net profit at Rs 443 crore for Q3FY24 as compared to Rs 292 crore for the same quarter in the previous year. Total income of the company increased by 8.79% at Rs 2699 crore for Q3FY24 as compared Rs 2481 crore for corresponding quarter of the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |